In the past few years, the united kingdom has witnessed a revolution in medical fat‑loss solutions — with the introduction of semaglutide (Wegovy®) into the developing attractiveness of tirzepatide (Mounjaro®). Now, One more identify is drawing awareness in the two medical and general public well